These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6713544)

  • 1. Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model.
    Lord EM; Burkhardt G
    Cell Immunol; 1984 May; 85(2):340-50. PubMed ID: 6713544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
    Lord EM
    Br J Cancer Suppl; 1980 Apr; 4():123-7. PubMed ID: 6932915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice.
    Lord EM; Nardella G
    Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional characteristics of cells infiltrating and destroying tumor multicellular spheroids in vivo.
    Lord EM; Penney DP; Sutherland RM; Cooper RA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Oct; 31(2):103-16. PubMed ID: 42207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multicellular spheroid as a model tumor allograft. I. Quantitative assessment of spheroid destruction in alloimmune mice.
    MacDonald HR; Howell RL
    Transplantation; 1978 Mar; 25(3):136-40. PubMed ID: 644649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multicellular spheroid as a model tumor allograft. II. Characterization of spheroid-infiltrating cytotoxic cells.
    MacDonald HR; Howell RL; McFarlane DL
    Transplantation; 1978 Mar; 25(3):141-5. PubMed ID: 306146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts.
    Sutherland RM; MacDonald HR; Howell RL
    J Natl Cancer Inst; 1977 Jun; 58(6):1849-53. PubMed ID: 140943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids.
    Wilson KM; Lord EM
    Br J Cancer; 1987 Feb; 55(2):141-6. PubMed ID: 3493024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of radiation on host-tumor interactions using the multicellular tumor spheroid model.
    Wilson KM; Lord EM
    Cancer Immunol Immunother; 1986; 23(1):20-4. PubMed ID: 2876773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy.
    Korbelik M; Krosl G; Krosl J; Dougherty GJ
    Cancer Res; 1996 Dec; 56(24):5647-52. PubMed ID: 8971170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular tumor spheroids of human colon carcinoma origin. Kinetic analysis of infiltration and in situ destruction in a xenogeneic (murine) host.
    Lees RK; Sordat B; MacDonald HR
    Exp Cell Biol; 1981; 49(4):207-19. PubMed ID: 7250481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH.
    Casciari JJ; Sotirchos SV; Sutherland RM
    J Cell Physiol; 1992 May; 151(2):386-94. PubMed ID: 1572910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor.
    Loeffler DA; Keng PC; Baggs RB; Lord EM
    Int J Cancer; 1990 Mar; 45(3):462-7. PubMed ID: 2307536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages.
    Wilson KM; Siegal G; Lord EM
    Cell Immunol; 1989 Oct; 123(1):158-65. PubMed ID: 2776218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Thomsen LL; Baguley BC; Wilson WR
    Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.
    Zwi LJ; Baguley BC; Gavin JB; Holdaway KM; Wilson WR
    Oncol Res; 1992; 4(8-9):333-9. PubMed ID: 1486217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity.
    Moran JP; Gerber SA; Martin CA; Frelinger JG; Lord EM
    Int J Cancer; 2003 Sep; 106(5):690-8. PubMed ID: 12866028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.